Data / Form D filings / Argonaute RNA Ltd
Argonaute RNA Ltd: Form D filing
Argonaute RNA Ltd, a biotechnology company in Cardiff, United Kingdom, filed a Form D with the SEC in 2026. The latest, on September 24, 2026, reports $1.8 million sold of a $1.8 million offering to 27 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CARDIFF BUSINESS TECHNOLOGY CENTRE SENGHENNYDD ROAD, Cardiff, United Kingdom, CF24
- Phone
- 00441179742562
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157150
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | New notice | $1,800,000 | $1,800,000 | 27 | Sep 9, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony Michael Parker | Executive Officer, Director | |
| Michael Mohamed Tarik Khan | Executive Officer, Director | |
| Richard Michael Tompkins | Director | |
| Johnathan Vincent Matlock | Director | |
| David William Dawson Ball | Director | |
| Alexander Michael Fink | Director | |
| Ross Thomas Burn | Director | |
| Nabil Hussain Muhiddin Al-Chalaby | Director | |
| Nigel Keith Davis | Director |
Every Form D from the week of Sep 21, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Argonaute RNA Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.